Abstract
Early detection of adverse drug reactions as a part of post-marketing surveillance is very crucial for saving a number of persons from unwanted consequences of drugs. Along with the drug, patient’s traits such as age, gender, weight, location are key factors for occurrence of adverse effects. The relationship between drug, patient attributes and adverse drug effects can be precisely represented by quantitative multi-dimensional association rules. But discovery of such rules faces the challenge of data sparsity because of the large number of possible side effects of a drug and fewer number of corresponding data records. In this paper, to address the data sparsity issue, we propose to use variable support based LPMiner technique for detecting quantitative multi-dimensional association rules. For experimental analysis, data corresponding to three cardiovascular drugs namely Rivaroxaban, Ranolazine and Alteplase has been taken from U.S. FDA Adverse Event Reporting System database. The experimental results show that based on LPMiner technique a number of association rules have been detected which went undetected in case of constant support based apriori and FP-Growth technique.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
George, C.: Reporting Adverse Drug Reactions: A Guide for Healthcare Professionals. British Medical Association, London (2006)
Rockville, M.D.: Reducing and Preventing Adverse Drug Events To Decrease Hospital Costs: Research in Action. Agency for Healthcare Research and Quality, Issue 1, March 2014
Chen, Y., Guo, J.J., Steinbuch, M.: Comparison of sensitivity and timing of early signal detection of four frequently used signal detection methods: an empirical study based on the US FDA adverse event reporting system database. Pharm Med. 22, 359–365 (2008)
World Health Organization (WHO): The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products (2002)
Lindquist, M.: The need for definitions in pharmacovigilance. Drug Saf. 30, 825–830 (2007)
World Health Organization: The Importance of Pharmacovigilance. WHO Collaborating Centre for International Drug Monitoring, Geneva, vol. 44 (2002)
U.S. Food and Drug Administration, FAERS quarterly data files. https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/default.Htm. Accessed Oct 2018
Han, J., Kamber, M.: Data Mining: Concepts and Techniques. Elsevier, Amsterdam (2011)
Wang, C., et al.: Exploration of the association rules mining technique for the signal detection of adverse drug events in spontaneous reporting systems. PloS One 7(7) (2012)
Yildirim, P., Ilyas, O., Holzinger, A.: On knowledge discovery in open medical data on the example of the FDA drug adverse event reporting system for alendronate (FOSAMAX). In: Holzinger, A., Pasi, G. (eds.) Human-Computer Interaction and Knowledge Discovery in Complex, Unstructured, Big Data, pp. 195–206. Springer, Heidelberg (2013)
Reps, J.M., Aickelin, U., Ma, J., Zhang, Y.: Refining adverse drug reactions using association rule mining for electronic healthcare data. In: Proceedings of IEEE International Conference on Data Mining Workshop (ICDMW 2014), pp. 763–770 (2014)
Yang, X., Albin, A., Ren, K., Zhang, P., Etter, J.P., Lin, S., Li, L.: Efficiently mining adverse event reporting system for multiple drug interactions. AMIA Summits Transl. Sci. Proc. 120 (2014)
Agrawal, R., Srikant, R.: Fast algorithms for mining association rules. In: Proceedings of 20th International Conference on Very Large Data Bases, VLDB, vol. 1215 (1994)
Han, J., Pei, J., Yin, Y.: Mining frequent patterns without candidate generation. In: ACM SIGMOD Record, vol. 29, no. 2. ACM (2000)
Seno, M., Karypis, G.: LPMiner: an algorithm for finding frequent itemsets using length-decreasing support constraint. In: Proceedings of IEEE International Conference on Data Mining (ICDM 2001) (2001)
Tan, P.-N.: Introduction to Data Mining. Pearson Education India, New Delhi (2007)
Sakaeda, T., Kadoyama, K., Okuno, Y.: Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations. Int. J. Med. Sci. 8(6), 487–491 (2011)
Dixon, J.K.: Pattern recognition with partly missing data. IEEE Trans. Syst. Man Cybern. 9, 617–621 (1979)
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Chutia, U., Sangma, J.W., Pal, V., Yogita (2020). Data-Driven Extraction of Quantitative Multi-dimensional Associations of Cardiovascular Drugs and Adverse Drug Reactions. In: Fdez-Riverola, F., Rocha, M., Mohamad, M., Zaki, N., Castellanos-Garzón, J. (eds) Practical Applications of Computational Biology and Bioinformatics, 13th International Conference. PACBB 2019. Advances in Intelligent Systems and Computing, vol 1005 . Springer, Cham. https://doi.org/10.1007/978-3-030-23873-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-23873-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23872-8
Online ISBN: 978-3-030-23873-5
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)